Strata Skin Sciences
SSKN
SSKN was delisted on the 18th of February, 2026.
18 hedge funds and large institutions have $1.48M invested in Strata Skin Sciences in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
2.07% more ownership
Funds ownership: 0.44% → 2.51% (+2.1%)
3% more capital invested
Capital invested by funds: $1.44M → $1.48M (+$48.7K)
10% less funds holding
Funds holding: 20 → 18 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$260K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$237K |
| 3 |
Bank of New York Mellon
New York
|
+$94.1K |
| 4 |
Renaissance Technologies
New York
|
+$53.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$39.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$350K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$14K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$11K |
| 4 |
BlackRock
New York
|
-$9.83K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$9K |
SSKN Hedge Fund Activity: Q2 2017 in Review
18 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q2 2017, worth a combined $1.48M — up 3.4% from $1.44M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SSKN and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Sabby Management, adding an estimated $260K. The largest seller was Broadfin Capital, cutting an estimated $350K.
- 18 institutional investors held Strata Skin Sciences (SSKN) as of Q2 2017, down from 20 in Q1 2017.
- Funds reported $1.48M of Strata Skin Sciences stock for Q2 2017, up 3.4% quarter-over-quarter.
- 3 funds opened new Strata Skin Sciences positions in Q2 2017 and 5 closed out, a net change of -2 holders.
- The largest Strata Skin Sciences buyer in Q2 2017 was Sabby Management, an estimated $260K added.
- The largest Strata Skin Sciences seller in Q2 2017 was Broadfin Capital, an estimated $350K sold.
Based on aggregated 13F filings for Q2 2017.